Proponents say the complication rate is low and usually short-lived. Folks who want to change their eye color can try iris tattooing or iris implants, but neither is approved by the U.S. Food and Drug ...

Opportunities for Advertisers and Publishers: Idil Cakim, Founder and CEO of the research company Iris Flex™, points to additional signals of innovation: "Voice-first audiences present a ...

MISSOULA — For those who were anxiously awaiting Iris's return, it might have ruffled your feathers, but no fear, she is back home. The early bird gets the worm, and Iris, Missoula's beloved ...

This is after the PNG Supreme Court ruled last week that parliament must be recalled on Tuesday, 8 April to debate a motion of no confidence against Marape. The court found that actions taken by the ...

Researchers discovered the blood vessels at the back of the eye -- called retinal microvasculature -- can show early signs someone is at risk of developing dementia. A new University of Otago ...

X user Alejandro commented on the official post, shedding light on the real reason behind this eye-catching look. He said, “These outfits aren't just made up. These are comic book characters ...

“People are out of their minds,” she said. ♦ Published in the print edition of the April 14, 2025, issue, with the headline “The Alien Eye.” Vauhini Vara consulted ChatGPT to help craft ...

Ukraine officials are hoping that Jett Cleary will make his Test debut in the end-of-season European Championships, as Australian-based players prepare to take on Thailand in June. Ukraine coach ...

Monster Hunter Wilds' Apple of Her Eye quest sends you out to find Alma's glasses, but leaves much of the guesswork up to you to figure out. The first quest marker points you in the right ...

Bangladesh's overtures to China for potential investments have raised concerns in India about the security of the strategically vital Siliguri Corridor, commonly known as the 'Chicken's Neck.' Listen ...

The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for its dry eye disease, rejecting its second application for approval and calling for data from at least one more study.